IL80896A - Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them - Google Patents

Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them

Info

Publication number
IL80896A
IL80896A IL80896A IL8089683A IL80896A IL 80896 A IL80896 A IL 80896A IL 80896 A IL80896 A IL 80896A IL 8089683 A IL8089683 A IL 8089683A IL 80896 A IL80896 A IL 80896A
Authority
IL
Israel
Prior art keywords
amino acid
acid sequences
herpes simplex
simplex virus
vaccine composition
Prior art date
Application number
IL80896A
Other languages
English (en)
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL80896(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of IL80896A publication Critical patent/IL80896A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL80896A 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them IL80896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it

Publications (1)

Publication Number Publication Date
IL80896A true IL80896A (en) 1990-02-09

Family

ID=26996451

Family Applications (5)

Application Number Title Priority Date Filing Date
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Family Applications After (4)

Application Number Title Priority Date Filing Date
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Country Status (20)

Country Link
US (1) US4762708A (enExample)
EP (1) EP0101506B1 (enExample)
JP (3) JP2665332B2 (enExample)
KR (1) KR910006889B1 (enExample)
AR (1) AR231496A1 (enExample)
AT (1) ATE54827T1 (enExample)
AU (1) AU554710B2 (enExample)
CA (1) CA1236774A (enExample)
DE (1) DE3381761D1 (enExample)
DK (1) DK172619B1 (enExample)
ES (1) ES519875A0 (enExample)
FI (2) FI73885C (enExample)
GR (1) GR77900B (enExample)
HU (1) HU195734B (enExample)
IE (1) IE56479B1 (enExample)
IL (5) IL80896A (enExample)
NO (2) NO162366B (enExample)
NZ (1) NZ220771A (enExample)
PH (1) PH25689A (enExample)
WO (1) WO1983002897A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
DE3683688D1 (de) * 1985-04-19 1992-03-12 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
RU2146134C1 (ru) * 1999-06-29 2000-03-10 Ласкавый Владислав Николаевич Антивирусный препарат для инъекций
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
ATE414176T1 (de) 2002-07-18 2008-11-15 Univ Washington Schnelle, effiziente reinigung von hsv- spezifischen t-lymphozyten und damit identifizierte hsv-antigene
US8541002B2 (en) * 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
CA2663109A1 (en) * 2006-09-08 2008-03-13 The Trustees Of The University Of Pennsylvania Hsv-1 and hsv-2 vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
JP6144448B2 (ja) * 2006-12-28 2017-06-07 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 単純ヘルペスウイルス複合サブユニットワクチンおよびその使用方法
WO2011106607A2 (en) 2010-02-26 2011-09-01 Juvaris Biotherapeutics, Inc. Subunit vaccines for herpes viruses and methods of use
WO2012139106A2 (en) * 2011-04-08 2012-10-11 Duke University Herpes simplex virus
HUE039215T2 (hu) 2012-05-16 2018-12-28 Immune Design Corp Vakcinák HSV-2-höz

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
IE53176B1 (en) * 1978-12-22 1988-08-17 Biogen Nv Recombinant dna molecules and their method of production

Also Published As

Publication number Publication date
ATE54827T1 (de) 1990-08-15
EP0101506A4 (en) 1984-07-06
FI864102A0 (fi) 1986-10-10
KR840003420A (ko) 1984-09-08
JPH0797396A (ja) 1995-04-11
FI83880C (fi) 1991-09-10
AU554710B2 (en) 1986-08-28
WO1983002897A1 (en) 1983-09-01
IL80895A (en) 1990-02-09
NO172745B (no) 1993-05-24
DE3381761D1 (de) 1990-08-30
NO842962L (no) 1983-10-17
NO172745C (no) 1993-09-01
NZ220771A (en) 1990-09-26
NO162366B (no) 1989-09-11
FI73885C (fi) 1987-12-10
JP2567202B2 (ja) 1996-12-25
FI864102L (fi) 1986-10-10
JPS59500216A (ja) 1984-02-16
PH25689A (en) 1991-09-04
FI833768A0 (fi) 1983-10-17
IE830332L (en) 1983-08-18
FI73885B (fi) 1987-08-31
AR231496A1 (es) 1984-12-28
AU1339683A (en) 1983-09-08
IL67930A0 (en) 1983-06-15
IE56479B1 (en) 1991-08-14
ES8406199A1 (es) 1984-08-01
DK479083D0 (da) 1983-10-17
FI83880B (fi) 1991-05-31
JP2665332B2 (ja) 1997-10-22
JP2669594B2 (ja) 1997-10-29
IL80895A0 (en) 1987-03-31
CA1236774A (en) 1988-05-17
GR77900B (enExample) 1984-09-25
IL80896A0 (en) 1987-03-31
ES519875A0 (es) 1984-08-01
EP0101506A1 (en) 1984-02-29
IL67930A (en) 1990-02-09
HU195734B (en) 1988-07-28
NO833773L (no) 1983-10-17
DK479083A (da) 1983-10-17
DK172619B1 (da) 1999-03-01
US4762708A (en) 1988-08-09
KR910006889B1 (ko) 1991-09-10
JPH0769924A (ja) 1995-03-14
EP0101506B1 (en) 1990-07-25
FI833768L (fi) 1983-10-17

Similar Documents

Publication Publication Date Title
IL80896A (en) Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
GB2178041B (en) Antigenic modification of peptides
IL72785A (en) Herpes simplex virus vaccines based on glycoproteins and process for making them
NZ220612A (en) 11 residue influenza virus peptide and vaccines
PH19645A (en) New derivatives of bicyclic amino acids and pharmaceutical composition containing them
DE3365492D1 (en) Diphosphonic acid derivatives and pharmaceutical preparations containing them
EP0332677A4 (en) Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
NZ218630A (en) Artificial polynucleotide coding for peptides of newcastle disease virus
GB2171103B (en) Novel peptides and peptide derivatives, their preparation and use and pharmaceutical compositions containing them
IL63627A (en) Phen(alk)oxy-substituted oxiranecarboxylic acids,processes for their preparation and pharmaceutical preparations containing them
DE3279468D1 (en) Peptide synthesis and amino acid blocking agents
IL74661A0 (en) Preparation of proteins
EP0101655A3 (en) Production of herpes simplex viral proteins
ZA835138B (en) Production of herpes simplex viral proteins
GB2126224B (en) Derivatives of w-amino acids the preparation and utilisation thereof and the compositions containing these derivatives
EP0084822A3 (en) Diphosphonic acid derivatives and pharmaceutical preparations containing them
JPS5779897A (en) Polypeptide containing amino acid arrangement of aged human corpuscle interferone
JPS55115851A (en) Recovery of amino acid from protein hydrolyzate
AU1678783A (en) Production of herpes simplex viral proteins
ZA831975B (en) Cathodic electrocoating finishes and their preparation
GB2193206B (en) Preparation of taurine-containing peptides
ZA864555B (en) Release of peptides from polypeptides
AU555413B2 (en) Preparation of halo-aldehydes and acid chlorides
ZA813781B (en) N-(vinblastinoyl-23)derivatives of amino acid and peptides
IL69274A (en) (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired